Upload Avatar (500 x 500)
Ren Xu
xuren526@xmu.edu.cn
Chinese, English, Japanese
Fujian
Xiamen University
Medical
  • 2001-2005 Bachelor: Anhui Normal University, School of Life Sciences
  • 2005-2008 Master: Xiamen University, School of Life Sciences
  • 2008-2013 PhD: Tokyo Medical and Dental University, Orthopedic Surgery
  • 2013-2014 - Tokyo Medical and Dental University Hospital - Special Researcher
  • 2014-2019 - Weill Cornell Medical College, USA - Postdoctoral Researcher
  • 2019-present - Xiamen University, School of Medicine - Professor, Doctoral Supervisor
  • 2019-present - Fujian Key Laboratory of Organ and Tissue Regeneration - Director
  • 2019-present - Xiamen University First Affiliated Hospital, Department of Orthopedics - Distinguished Director
  • 2013: Japanese Ministry of Education Global Outstanding Program - 'Super Student' Title
  • 2017: International Chinese Musculoskeletal Research Society (ICMRS) Webster Jee Young Investigator Award
  • 2018: International Society of Bone Immunology Young Investigator Award
  • 2018: American Society for Bone and Mineral Research (ASBMR) Annual Meeting Young Investigator Award
  • 2019: American Institute for Medical and Biological Engineering (AIMM) John Haddad Young Investigator Award
  • 2019: Fujian Province 'Minjiang Scholar' Recipient
  • 2020: Fujian Province High-Level Talent Introduction
  • 2021: National Overseas High-Level Young Talent (Central Organization Department)
  • 2022: Xiamen City 'Double Hundred Plan' High-Level Innovative Talent
  • 2022: Fujian Province 'Outstanding Youth Science Fund' Recipient
Mechanisms of bone-specific nerve/vascular systems in degenerative diseases
Identification and differentiation hierarchy of skeletal stem/progenitor cell subtypes
Systemic functions of bone-forming cell factors in metabolic diseases
  • Sema3A regulates bone-mass accrual through sensory innervations., Fukuda T, Takeda S, Xu R, Ochi H, Sunamura S, Sato T, Shibata S, Yoshida Y, Gu Z, Kimura A, Ma C, Xu C, Bando W, Fujita K, Shinomiya K, Hirai T, Asou Y, Enomoto M, Okano H, Okawa A, Itoh H., 2013
  • c-Jun N-terminal kinases (JNKs) are critical mediators of osteoblast activity in vivo., Xu R, Zhang C, Shin DY, Kim JM, Lalani S, Li N, Yang YS, Liu Y, Eiseman M, Davis RJ, Shim JH, Greenblatt MB., 2017
  • Targeting skeletal endothelium to ameliorate bone loss., Xu R, Yallowitz A, Qin A, Wu Z, Shin D, Kim J, Debnath S, Ji G, Bostrom M, Yang X, Zhang C, Dong H, Kermani P, Lalani S, Li N, Liu Y, Poulos M, Wach A, Zhang Y, Inoue K, Lorenzo A, Zhao B, Butler J, Shim J, Glimcher L, Greenblatt MB., 2018
  • Osteoclasts are not a source of SLIT3., Li N, Inoue K, Sun J, Niu Y, Lalani S, Yallowitz A, Yang X, Zhang C, Shen R, Zhao B, Xu R, Greenblatt MB., 2020
  • SLITRK5 is a novel negative regulator of hedgehog signaling in osteoblasts., Sun J, Shin YD, Eiseman M, Yallowitz AR, Li N, Lalani S, Li Z, Cung M, Bok S, Debnath S, Marquez SJ, White TE, Khan A, Lorenz I, Shim J, Lee FS, Xu R, Greenblatt MB., 2021
Bone Nerve Vascular Degenerative Diseases Stem Progenitor Cell Differentiation Metabolic

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.